Biblio Discovery — Demo Discovery Service

4 hasil untuk "Yi-Cheng Lin"

Menampilkan 1–4 · 0,31 detik · RSS

  1. Artikel Jurnal Teks lengkap

    The stability of long-segment and short-segment fixation for treating severe burst fractures at the thoracolumbar junction in osteoporotic bone: A finite element analysis

    Yueh Wu; Chia-Hsien Chen; Fon-Yih Tsuang dkk.

    PLOS ONE, Vol. 14 No. 2 · 2019 · Inggris · PLOS Scopus

    The majority of compressive vertebral fractures in osteoporotic bone occur at the level of the thoracolumbar junction. Immediate decompression is often required in order to reduce the extent of neurological damage. This study evaluated four fixation methods for decompression in patients with…

  2. Artikel Jurnal Teks lengkap

    Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction

    Chih-Wei Chen; Chun-Wei Chang; Yi-Cheng Lin dkk.

    PLOS ONE, Vol. 18 No. 9 · 2023 · Inggris · PLOS Scopus

    Background: Angiotensin receptor blockers (ARBs) are considered an alternative to angiotensin-converting enzyme inhibitors (ACEIs) in patients with acute myocardial infarction (AMI), but in the era of extensive use of preventive therapies and percutaneous coronary intervention, this has not been…

  3. Artikel Jurnal Teks lengkap

    Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease

    Chih-Chin Kao; Mai-Szu Wu; Ming-Tsang Chuang dkk.

    PLOS ONE, Vol. 16 No. 8 · 2021 · Inggris · PLOS Scopus

    Background: Dual antiplatelet therapy (DAPT) is currently the standard treatment for the prevention of ischemic events after stent implantation. However, the optimal DAPT duration remains elusive for patients with chronic kidney disease (CKD). Therefore, we aimed to compare the effectiveness and…

  4. Artikel Jurnal Teks lengkap

    Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study

    Yi-Cheng Lin; Bi-Li Chen; Chun-Ming Shih dkk.

    PLOS ONE, Vol. 16 No. 4 · 2021 · Inggris · PLOS Scopus

    Background: The optimal anticoagulant for end-stage renal disease patients for stroke prophylaxis is unknown. The efficacy and safety of warfarin in this population are debatable. In addition, real-world evidence of direct oral anticoagulants in patients with end-stage renal disease is limited. The…